A putative HIV-1 subtype C/CRF11_cpx unique recombinant from South Africa
© Bessong and Iweriebor. 2016
Received: 12 September 2015
Accepted: 22 February 2016
Published: 5 March 2016
The HIV epidemic in South Africa is overwhelmingly driven by HIV-1 subtype C viruses. The HIV gag, pol, env (C2-V5) and nef sequences of virus 08MB26ZA, obtained from a 47 year old woman, were studied by phylogenetic analysis, REGA and the jumping Profile Hidden Markov Model (jPHMM) tools. The pol gene was further analyzed for recombination by Simplot. The pol and env sequences were examined for genetic drug resistance mutations and predicted co-receptor usage respectively. There was agreement in the assignment of the gag sequence as pure HIV-1 subtype C by phylogenetic, REGA and jPHMM analyses. The pol sequence clustered with CRF11_cpx and in the J-clade by phylogenetic analysis; and to a CRF11_cpx/subtype C recombinant by REGA. The assignment of pol to CRF11_cpx and subtype C was confirmed by Simplot. The recombinant was of the R5 biotype, with no important drug resistance mutations in the pol region. The epidemiologic and biologic significance of the virus are unknown. The finding suggests that complex viruses are being introduced into South Africa with potential implications for diagnosis. This is apparently the first report from South Africa of a putative unique recombinant involving CRF11_cpx and subtype C genomes.
KeywordsHIV-1 subtype C CRF11_cpx Recombinant HIV subtyping South Africa
Genetic variants of HIV contribute to the pandemic worldwide and have potential consequences for diagnostics, treatment and treatment monitoring, and the development of an effective vaccine (Hemelaar 2013). Several factors account for the high genetic diversity of HIV: rapid replication turnover, in vivo host selective immune and treatment pressure, and recombination events during replication (Liitsola et al. 1998; Corbet et al. 2000; Ramirez et al. 2008; Taylor et al. 2008). Due to this variability, HIV is classified into types 1 and 2; with type 1 further classified into groups M, O, N and P. Group M, which is responsible for the global HIV-1 epidemic, comprises nine recognized phylogenetic subtypes (A–D, F–H, J, and K), with further divisions into sub-subtypes for A and F viruses.
The emergence of circulating recombinant forms (CRFs) in the global HIV-1 pandemic is important, as together with unique recombinant forms (URF) represent about 20 % of infections (Hemelaar et al. 2011). A complex (cpx) variant represents a recombinant derived from genes of three pure subtypes. CRF11_cpx involving subtypes A, G, J and CRF01-AE is observed in the Republic of Congo, Cameroon and Central African Republic (Wilbe et al. 2000; Montavon et al. 2002). Analysis of partial sequences suggests the presence of CRF11_cpx in Senegal and Gabon (Paraskevis et al. 2000). Subtype J was discovered in 1995 and originated most probably in the Democratic Republic of Congo. Few subtype J sequences are available, and these are mostly from the Democratic Republic of Congo, Cameroon, and Senegal (Los Alamos Database 2014). However, fragments of subtype J are present in many mosaic recombinant forms originating from West Africa (CRF06_cpx) and Central West Africa (CRF11_cpx, CRF13_cpx, and CRF49_cpx), suggesting that this subtype, either in a pure or in a recombinant form, is probably prevalent across Central and West Africa (Laukkanen et al. 1999). Subtype J sequences have also been reported in Uganda, Angola, Zambia, Cuba, Spain and France (Trask et al. 2002; Yebra et al. 2013; Bartolo et al. 2009; Kiwanuka et al. 2009).
Human immunodeficiency type 1 subtype C is overwhelmingly responsible for the epidemic in South Africa, although over time, other subtypes such as A, D, CRF01_AE, inter-subtype and URF such as A1/C, A1/D have been identified (Bredell et al. 2002; Iweriebor et al. 2011; Wilkinson and Engelbrecht 2009). However, CRF11_cpx has not been reported from South Africa. In this report, a plausible recombinant, comprising sequences from HIV-1 subtype C and CRF11_cpx identified in a South African patient is described.
Results and discussion
Phylogenetic analyses of gene regions
In an initial phylogenetic analysis, the partial pol sequence [complete protease (PR) and first 900 bp of the reverse transcriptase (RT)] clustered with CRF11_cpx reference sequences. Additional recombination analysis with REGA tool revealed a mosaic pattern of unclassified regions alternating with subtype J regions (Nwobegahay et al. 2011). Consequently, an attempt was made to further elucidate the genetic makeup of the virus.
Subtype and recombination analyses of gag and pol genes by REGA
The assignment of the pol sequence as related to CRF11-cpx/C was according to the REGA schedule 3A which is based on 4 parameters: the query sequence greater than 800 bp, clustering with a CRF with a bootstrap confidence greater than 70 %, coupled with the detection of recombination in the pure subtype bootscan, and further confirmed by CRF bootscan analysis with a confidence of more than 90 % (Peña et al. 2012).
Subtype and recombination analysis by jPHMM and Simplot
Summary of subtype assignments by phylogenetic, REGA and jPHMM HIV subtyping and recombination analyses of 08MB26ZA
HIV-1 subtype C
HIV subtype C
HIV-1 subtype C
HIV subtype J
HIV-1 subtype J
HIV-1 subtype J/C
Outlier to HIV-1 subtype C
HIV-1 subtype C
HIV-1 subtype C/A1
CRF11_cpx/HIV-1 subtype C
HIV-1 subtype J/C/K
HIV-1 subtype C
HIV-1 subtype C
HIV-1 subtype C
Outlier to HIV-1 subtype C
HIV-1 subtype C
HIV-1 subtype C
There was agreement among the analytic tools in inferring subtypes and recombination patterns for some of the genes regions and not for others. For example, jPHMM indicated the presence of subtype A1 sequences in the IN gene in addition to subtype C sequences; and also the presence subtype K sequences in the pol gene. The jPHMM indicated the presence of subtype J sequences in the pol gene in contrast to CRF11_cpx indicated by phylogenetic analysis and REGA. This discrepancy can however be reconciled in that subtype J sequences constitute a significant component of CRF11_cpx viruses. Consequently, the indication by phylogenetic analysis, REGA and Simplot tools of the presence of CRF11_cpx sequences in the pol gene, in addition to the assignment of the gag, env and nef genes to subtype C overwhelmingly suggests that virus 08MB26ZA harboured HIV-1 subtype C and HIV-1 CRF11_cpx sequences.
The partial characterization of a CRF11_cpx/HIV-1 subtype C-like virus from a 47 year old South African female is reported. The current analysis shows that the virus differed markedly from pure HIV-1 subtype J and CRF11_cpx in its sub-genomic assignments. It is only in the PR and RT genes that it exhibited a related pattern of mosaicism as seen in CRF11_cpx. The entire genome of CRF11_cpx is partitioned into sub-genomic regions comprising subtypes A, J, U, G and CRF01_AE (Paraskevis et al. 2000), and in 08MB26ZA subtype G and J sequences were also identified in the pol gene by REGA analysis. The gag of 08MB26ZA is related to subtype C, whereas in CRF11_cpx, it is derived from subtype A. Similarly, the IN, env C2-V5 and nef genes of 08MB26ZA are related to subtype C, whereas in CRF11_cpx the IN and env C2-V5 genes are derived from subtype A and nef is derived from CRF01_AE. HIV-1 subtype J and CRF11_cpx are predominantly found in the Central African region (Koyalta et al. 2009; Torimiro et al. 2009; Ndembi et al. 2008; Caron et al. 2012), with few reports from Southern Africa (Angola and Zambia) on the presence of subtype J viruses (Trask et al. 2002; Yebra et al. 2013; Bartolo et al. 2009).
Availability of the complete genome would have afforded a detailed understanding of the mosaic nature of virus 08MB26ZA allowing for a full comparison with CRF sequences in the sequence database. However, a search of the Los Alamos HIV sequence database did not reveal any variant that contains HIV-1 subtype C and CRF11_cpx sequences in its genomic composition. In another vein, since population based sequencing was employed it is not possible to rule out dual infection with HIV-1 subtype C and CRF11_cpx. However, CRF11_cpx has not been reported from South Africa. It is also understood that the patient from whom the virus under investigation was recovered had never travelled out of South Africa, increasing the likelihood that the observation could be an infection with a recombinant CRF11_cpx/HIV-1-C like virus. It is important to note that this is a description of a virus from a single individual harboring genes from an HIV circulating recombinant form (CRF11_cpx) and a pure HIV subtype (HIV-1 subtype C). Therefore, the implications in terms of its epidemiologic and biologic preferences are unknown.
Genotypic drug resistance and co-receptor usage analyses
Drug resistance genotypic analysis of the PR, RT and IN genes did not reveal the presence of primary or major drug resistance mutations. However, examination of the PR revealed the following amino acid substitutions; L10V, T12P, K14R, I15 V, G16A, A28P and T31R and V32L; while in the RT the following amino acid amino acid substitutions I5 V, E6D, V35T, T39L, K122 N, K173T, D177G, T200E, I202V, R211K, V245N, E248D, D250E, A272P, E293 V, I329 V, Q334L, G335D, R356K, M357R, R358K, G359A, K366R, T369A, A371V, T377L, K390R, K395R, A400T, E435A, and A437V were observed in comparison with the global subtype B consensus sequence. Similarly, the following amino acid substitutions; K14R, S24N, D25E, V31I, M50I, I72V, V99F, F100Y, T112V, T124N, T125A, K136Q, V201I, Y227F, L234I, N254K, S255G, and S283G were observed in the IN when compared with the global subtype B consensus sequence. These amino acid changes are of unknown phenotypic significance. However, in the absence of primary or major drug resistant associated mutations it is expected that virus 08MB26ZA would be susceptible to currently used antiretroviral (ARV) drugs in South Africa.
The V3 loop is a major determinant for viral tropism and co-receptor usage. Analysis of the V3 loop of 08MB26ZA showed it had the GPGQ tetrapeptide motif and co-receptor usage prediction with webPSSM showed it was a CCR5 virus with a net charge of +3. This co-receptor prediction suggests that the virus would be susceptible to entry inhibitors such as Maraviroc.
The identification of a CRF11_cpx/HIV-1 subtype C-like recombinant virus from South Africa, a region with an overwhelming predominance of HIV-1 subtype C, has been described. This is a signal suggesting the likely introduction of new and complex genetic variants in South Africa; and highlights the importance for regular genetic diversity studies due to potential implications for diagnosis. Apparently, this is the first report of a putative CRF11_cpx/HIV-1 subtype C unique recombinant from South Africa.
Blood was collected from a 47 year old female (08MB26ZA) from Capricorn district, South Africa in 2008. At the time of blood collection, the patient was not on ARV. The CD4+ cell count and plasma viral load measurements were not available. The route of infection was heterosexual and the probable year of infection was 2005.
Research ethics considerations
The study protocol was approved by the Safety, Health and Research Ethics Committee of the University of Venda, South Africa. Signed informed consent was obtained before blood sample and demographic data were collected.
Generation of gene regions by PCR
Viral DNA was obtained from patient’s peripheral blood mononuclear cells using QIAamp DNA kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. The gag, pol, env C2-V5 and nef genes were amplified by nested PCR. The first round PCR of the different fragments were amplified using one of the following primer pairs; GagDrev 5′-AAT TCC TCC TAT CAT TTT TGG -3′ and Gag Dforw 5′-TCT CTA GCA GTG GCG CCC G-3′ for gag; Pol1C; 5′-GAA GGA CAC CAA TTG AAA GAC TGC AC-3′ and INrev1; 5′-TCT CCT GTA TGC AGA CCC CAA TAT-3′ for pol, while ED5;5′-ATG GGA TCA AAG CCA TGT G-3′ and ED12; 5′-ATG GCT TCC TGC TCC CAA GAA CCC AAG-3′ were used for the env C2-V5; and SQ15FC; 5′-GAG AGC GGT GGA ACT TCT-3′ and NefOR; 5′-AGG CAA GCT TTA TTG AGG-3′ for the nef gene.
The amplifications were carried out in a reaction mixture containing 5 µl of 10× buffer, 200 µM of dNTPs, 0.5 µM of each primer, 0.5 U of Taq Expand Long Template, and 10 µl of DNA template in a final reaction volume of 50 µl. The cycling conditions used for all the reactions were as follows: 94 °C for 3 min followed by 35 cycles of 94 °C for 30 s, 55 °C for 45 s and 72 °C for 2 min; and a final extension for 10 min at 72 °C. The nested reaction was carried out in a reaction mixture and cycling conditions as outlined above but with the following primer pairs Gag Aforw 5′-CTC TCG ACG CAG GAC TCG GCT T-3′ and GagCrev; 5′-TCTTCTAATACTGTATCATCTGC-3′ for the gag gene; GagP1 5′-CAAGGG GAGGCCAGGGAATTT-3′ and INrevII 5′-CCTAGTGGGATGTGTACTTCTGA-3′ for the pol gene; ES7 5′-CTGTTAAATGGCAGTCTAGC-3′ and ES8 5′-CACTTCTCC AATTGTCCCTCA-3′ for env C2–V5; and Nefforw 5′-CCTAGAAGAATAAGACAG GGCTT-3′ and Nefrev 5′-CCTGGAACGCCCCAGTGG-3′ for the nef gene region. The amplified products were purified and directly sequenced using a BigDye Terminator sequencing kit (Applied Biosystems, Foster City, CA) making use of appropriate sequencing primers for the gag and pol genes while the env and nef were sequenced with their nested primers. The sequenced fragments from both strands were assembled and edited using SeqMan Pro and Seqbuilder program contained in the DNAStar software version 7 (DNASTAR, INC, Madison, Wisconsin, USA).
Phylogenetic and recombination analyses
The gag, pol, PR, RT, IN, env C2-V5, and nef sequences were aligned with pure subtypes A–D, F–H, J, K, and CRF11_cpx reference sequences obtained from the Los Alamos database. Test and reference sequences were codon aligned using Muscle and phylogenetic trees generated by the maximum likelihood method as implemented in MEGA version 5.2 with 1000 bootstrap replicates to estimate the reliability of the branching clusters (Tamura et al. 2011). The gag and pol sequences were additionally analyzed for recombination and CRF with REGA HIV Subtyping tool version 3.0 (Peña et al. 2012). The REGA tool employs phylogenetic and bootscanning methods to assess the query sequence against a mirror of pure subtypes and CRFs. Additionally, the pol sequence was analysed by jPHMM and Simplot to confirm recombination.
Determination of genotypic drug resistance and co-receptor usage
The PR, RT and IN nucleotide sequences were also submitted to the Stanford HIV Drug Resistance Interpretation Algorithm for the detection of mutations associated with drug resistance and closest subtype identity (Stanford HIV drug resistance mutation database). The V3 loop of the env gene is a major determinant for viral tropism and co-receptor usage. The predicted amino acid sequences of the V3 loop of virus 08MB26ZA was submitted to the webPSSM, an online interactive program that predicts co-rector usage of viruses by calculating the net charge of the V3 loop and makes predictions on probable co-receptor usage (WebPSSM).
GenBank accession numbers
The gene regions described here have been deposited in GenBank under the following accession numbers: HM049909 (gag); GU188817 (PR); HM049908 (RT); HM049906 (IN); HM049910 (env C2-V5); HM049907 (nef).
BI generated the nucleotide sequences. POB designed the study, analyzed the data and wrote the manuscript. Both authors read and approved the final manuscript.
The cooperation of the study participant is appreciated. This study was carried out with the support from a grant awarded to POB by the National Department of Health, under the Comprehensive HIV and AIDS Care, Treatment and Management Plan for South Africa. Additional support was obtained from the National Research Foundation, South Africa (Grant UID 80576 to POB). The opinions expressed here are those of the authors.
BI declares no conflict of interest. POB is an editorial advisory board member of SpringerPlus.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Bartolo LM, Epalanga M, Bartolomeu J, Fonseca M, Mendes A, Gama A, Taveira N (2009) High genetic diversity of human immunodeficiency virus type 1 in Angola. AIDS Res Hum Retroviruses 21:306–310View ArticleGoogle Scholar
- Bredell H, Hunt G, Casteling A, Cilliers T, Rademayer C (2002) HIV-1 subtypes A, D, G, AG and unclassified sequences identified in South Africa. AIDS Res Hum Retroviruses 18:681–683View ArticleGoogle Scholar
- Caron M, Kekana-Douki SE, Makuwa M et al (2012) Prevalence, genetic diversity and antiretroviral drug resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, Central Africa. BMC Infect Dis 12:64. doi:https://doi.org/10.1186/1471-2334-12-64 View ArticleGoogle Scholar
- Corbet S, Muller-Trutwin MC, Versmisse P, Delarue S, Ayouba A, Lewis J, Brunak S (2000) Env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol 74:529–534View ArticleGoogle Scholar
- Hemelaar J (2013) Implications of HIV diversity for the HIV-1 pandemic. J Infect 66:391–400View ArticleGoogle Scholar
- Hemelaar J, Gouws E, Ghys PD, Osmanov S (2011) WHO-UNAIDS network for HIV isolation and characterisation. Global trends in molecular epidemiology of HIV-1 during 2000–2007. AIDS 25:679–689View ArticleGoogle Scholar
- Iweriebor BC, Bessong PO, Mavhandu LG, Masebe TM, Nwobegahay J, Moyo SR, Mphahlele JM (2011) Genetic analysis of the near full-length genome of an HIV type 1 A1/C unique recombinant form from Northern South Africa. AIDS Res Hum Retroviruses 27:911–915View ArticleGoogle Scholar
- Kiwanuka N, Layendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH (2009) HIV-1 subtypes and differences in heterosexual HIV transmission among discordant couples in Rakai, Uganda. AIDS 23:2479–2484View ArticleGoogle Scholar
- Koyalta D, Charpentier C, Beassamda J, Rey E, Si-Mohamed A, Djemadji-Oudjeil N, Bélec L (2009) High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N’Djamena, Chad. Clin Infect Dis 49:155–159View ArticleGoogle Scholar
- Laukkanen T, Albert J, Littsola K, Green SD, Carr JK, Leitner T, McCutchan FE, Salminen MO (1999) Virtually full-length sequences of HIV type 1 subtype J reference strains. AIDS Res Hum Retroviruses 15:293–297View ArticleGoogle Scholar
- Liitsola K, Tashkinova I, Laukkanen T, Korovina G, Smolskaja T, Momot O, Mashkilleyson N (1998) HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 12:1907–1919View ArticleGoogle Scholar
- Los Alamos National Laboratory database (2014) http://www.hiv.lanl.gov/content/index. Accessed 15 Dec 2013
- Montavon C, Vergne L, Bourgeois A, Mpoudi-Ngole E, Malonga-Mouellet G, Butel C, Toure-Kane C, Delaporte E, Peeters M (2002) Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res Hum Retroviruses 18:231–236View ArticleGoogle Scholar
- Ndembi N, Abraha A, Pilch H, Ichimura H, Mbanya D, Kaptue L, Salata R, Arts EJ (2008) Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaoundé, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol 46:177–184View ArticleGoogle Scholar
- Nwobegahay JM, Bessong PO, Masebe TM, Mavhandu LG, Iweriebor BC, Selabe G (2011) Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa. J Health Popul Nutr 29:303–309View ArticleGoogle Scholar
- Paraskevis D, Magiorkinis M, Paparizos V, Pavlakis GN, Hatzakis A (2000) Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences. AIDS Res Hum Retroviruses 16:845–855View ArticleGoogle Scholar
- Peña ACP, Faria NR, Imbrechts S, Libin P, Abecasis AB, Deforche K, Gomez A, Camacho RJ, de Oliveira T, Vandamme AM (2012) Performance of the subtyping tools in the surveillance of HIV-1 epidemic: comparison between Rega Version 3 and six other automated tools to identify pure subtypes and circulating recombinant forms. In: Proceedings of the 17th international bioinformatics workshop on virus evolution and molecular epidemiology. University of Belgrade, Faculty of Medicine, Belgrade, Serbia, 27–31 Aug 2012Google Scholar
- Ramirez BC, Simon-Loriere E, Galetto R, Negroni M (2008) Implications of recombination for HIV diversity. Virus Res 134:64–73View ArticleGoogle Scholar
- Tamura K, Peterson D, Perterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739View ArticleGoogle Scholar
- Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM (2008) The challenges of HIV-1 subtype diversity. N Engl J Med 358:1590–1602View ArticleGoogle Scholar
- Torimiro JN, D’Arrigo R, Takou D, Nanfack A, Pizzi D, Ngong I, Carr JK, Joseph FP, Perno CF, Cappelli G (2009) Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon. New Microbiol 32:325–331Google Scholar
- Trask SA, Derdeyn CA, Fideli U, Chen Y, Meleth S, Kasolo F, Musonda R, Hunter E, Gao F, Allen S, Hahn BH (2002) Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J Virol 76:397–405View ArticleGoogle Scholar
- WebPSSM. http://indra.mullins.microbiol.washington.edu/pssm/webpssm3.pl. Accessed 30 Nov 2013
- Wilbe K, Casper C, Albert J, Leitner T (2000) Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13_cpx) of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses 18:849–856View ArticleGoogle Scholar
- Wilkinson E, Engelbrecht S (2009) Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa. Infect Genet Evol 9:840–846View ArticleGoogle Scholar
- Yebra G, de Mulder M, Holguín A (2013) Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain. PLoS One. doi:https://doi.org/10.1371/journal.pone.0064293 Google Scholar